Mylan delays merger with Upjohn due to COVID-19 pandemic

Mylan delays merger with Upjohn due to COVID-19 pandemic
Mylan NV's corporate center at Southpointe. (Paul. J. Gough)

PITTSBURGH — The Mylan NV-Upjohn merger is being pushed back into the second half of 2020 due to the COVID-19 global pandemic.

Mylan NV (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE), which owns Upjohn, announced Thursday that COVID-19 is moving the expected merger date from the first half of the year and Mylan’s meeting of shareholders to approve it is being moved from April 27 to June 30.

Read more in the Pittsburgh Business Times.

Content Continues Below
Attorney generals in 32 states, including Pa., cracking down on price gouging